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Abstract: The social amoeba Dictyostelium discoideum provides an excellent model for research across
a broad range of disciplines within biology. The organism diverged from the plant, yeast, fungi and
animal kingdoms around 1 billion years ago but retains common aspects found in these kingdoms.
Dictyostelium has a low level of genetic complexity and provides a range of molecular, cellular,
biochemical and developmental biology experimental techniques, enabling multidisciplinary studies
to be carried out in a wide range of areas, leading to research breakthroughs. Numerous laboratories
within the United Kingdom employ Dictyostelium as their core research model. This review introduces
Dictyostelium and then highlights research from several leading British research laboratories, covering
their distinct areas of research, the benefits of using the model, and the breakthroughs that have
arisen due to the use of Dictyostelium as a tractable model system.
Keywords: chemotaxis; Dictyostelium discoideum; slime mould; social amoeba; phagocytosis; au-
tophagy; macropinocytosis; development
1. Introduction
Dictyostelium-like species have been found in fossil records from 2.1 billion years
ago [1], at the very beginning of multicellularity, positioning the Amoebozoa kingdom
very early on in eukaryotic evolution. The family Dictyostelia is estimated to have evolved
around 1 billion years ago [2]. Arising from this, the modern day Dictyostelium discoideum,
which was originally called a ‘slime mould’, was initially used as a research model by
Kenneth Raper in the 1930s [3–5] and then, later, by John Bonner [6,7], both of whom
were fascinated with the development of this species as it transitions from a single celled
‘amoeboid’ form to a multicellular ‘fruiting body’. Over the following 90 years, research
using Dictyostelium has provided fundamental insights into the biology of cell function
and the process of multicellular development from a single cell to a mature fruiting body
containing up to one million differentiated cells. It remains, by far, the best investigated
model organism within the large group of the Amoebozoa.
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The central reproductive cycle of Dictyostelium involves mitotic, single-cell division in
the presence of nutrients. In nature, Dictyostelium cells are found in leaf litter in many habi-
tats [8], where they consume microorganisms through a process called phagocytosis. The
events leading to multicellularity are initiated at the onset of starvation (Figure 1), where
an emerging process of collective cell signalling leads to a change in gene transcription
and cell behaviour to promote multicellularity. Collective signalling guides directional cell
movement, called chemotaxis, where cells both generate and sense a temporal gradient
of cyclic AMP (cAMP), due to its secretion and the release of phosphodiesterase enzymes
(PDEs) that degrade it [9]. Through this process, cells converge towards a dominant sig-
nalling centre (aggregation), to form ‘mounds’, within which cells continue to move in a
spiralling pattern and initiate developmental changes into different cell types (primarily
early spore and stalk cells). Further development of the mound leads to a ‘first-finger’
stage that can continue to develop through forming a ‘slug’ of around 1 mm in length. This
slug is adapted to move towards light (phototaxis) [10], which is presumed to provide a
means for the developing multicellular structure to rise above the leaf litter. Development
continues, either directly from the finger stage or after slug formation, to form a mature
fruiting body consisting of dead vacuolated stalk cells holding aloft a spore head (sorus)
containing dormant and desiccation/starvation/temperature-resistant spores. Ultimately,
spores released from the fruiting body germinate, renewing the cycle of single-cell division
in the presence of nutrients.
‘mounds’, within which cells continue to 
(primarily early spore and stalk cells). Further development of the mound leads to a ‘first
finger’ stage that can continue to develop through forming a ‘slug’ of around 1
Figure 1. Dictyostelium discoideum has both single-celled and multicellular phases in its life cycle.
Dictyostelium cells proliferate in the unicellular phase by mitotic division. Upon starvation, cells
aggregate through chemotaxis to cAMP. Development proceeds through streaming, mound and
tipped mound formation, leading to the multicellular finger stage. At this stage, development can
bifurcate, either forming a migratory slug-like structure or progressing straight to an early culminant
and finally a mature fruiting body of around 1 mm in height, containing spores in a spherical spore
head. These dormant cells are resistant to dehydration and starvation and, subsequently, are released
to renew their cycle of unicellular growth.
Modern Dictyostelium research has flourished in a number of different directions due
to a range of factors including the simple nature of the model, its distinct processes of
growth and development, and a unique combination of research techniques. Dictyostelium
represents a cellular model system with typical eukaryotic cell characteristics, including
nuclei, Golgi apparatus, mitochondria and endoplasmic reticulum. The haploid genome
of Dictyostelium has been fully characterised and annotated (dictybase.org) [11], including
descriptions of each protein, phenotypes of mutants lacking individual proteins and related
published material. The central focus of much research in this model remains in the areas of
cell movement, communication and development. However, a range of other research areas
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have been well represented by Dictyostelium researchers including biomedical sciences [12,13]
and neurodegeneration [14–17]; infection and immunology [18,19]; autophagy [20,21]; social
cooperativity [22]; and cancer and DNA repair [23]. The reasons for using Dictyostelium as a
research model derive from a range of key advantages over mammalian systems including.
• A simple system
– A compact genome with reduced functional redundancy compared with mam-
malian cells, allowing clear analysis of mutant phenotypes;
• Developmental biology
– Distinct lifecycles of single and multicellular phases, allowing the analysis of
decisions specifically affecting cell proliferation and differentiation;
• Biochemistry
– The rapid and inexpensive production of multiple grams of isogenic cells, for
example, to analyse enzyme activity, metabolic changes, organelle function or
development;
• Genetics and cell biology
– A genome wide Dictyostelium mutant library, providing the ability to screen the
genome for gain or loss of function phenotypes [24];
– Rapid (multiple) gene ablation or overexpression in isogenic cell lines to identify
and characterise protein function (including human proteins) [25];
• Microscopy
– Advanced microscopy techniques to visualize, monitor and analyse protein and
RNA dynamics;
• Pharmacology
– Pharmacogenetic approaches, where screening of mutant-cell libraries can identify
the genetic basis of cell or developmental behaviour or how drugs or related
compounds act in cells (i.e., mechanism of action studies);
– The rapid analysis of compound effects on normal cell function, including acute
and chronic exposure and structure/activity studies.
In this review, we highlight some of the world-leading research in the field of Dic-
tyostelium biology arising from UK-based researchers. These research excerpts are used
to introduce the various areas that are being investigated using this model, show how
Dictyostelium provides an advantageous system for research, detail the arising discoveries,
and demonstrate the wider impact of these studies.
2. Understanding Cell Fate Decisions
Despite intense activity in the field of developmental biology for many decades, our
understanding of how cells make decisions about their fate is decidedly limited. Models
tend to fall into two categories—instructive or permissive. Instructive models emphasise
the external or inherited trigger, giving the cell no choice. Permissive models view the
cell as waiting for some event that triggers a decision that has already been made, often
incorporating a central “noise plus feedback” element. These models can be useful in the
limited number of apparently simple contexts in which cell fate appears to be determined
by a limited number of components. However, in most systems, which are neither wholly
instructive nor permissive and often depend on a highly complex set of interactions
between the cell and its environment [26], these opposing models lack utility.
Although progress has been made by studying specific molecules, these approaches
do not reveal the complexity of the niche that interacts with the cell, and we are far from
having a fully parameterised catalogue of all the salient molecular interactions occurring
both inside and outside the cell. The primary problem we face is determining the appro-
priate level of organisation at which we should focus our efforts and measuring all of
the implicated agents in the decision-making process (such as signals, cells, transcription
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factors, etc.) within a meaningful physiological dynamic range. Ideally all of the major sig-
nalling inputs and cellular responses should be quantified in real time in the physiological
niche. These measurements require monitoring of the dynamics, strength and distribution
of signals, together with multiple real-time readouts of cell states, such as transcription,
motility and proliferation.
These approaches are challenging to bring together in vivo; however they can be
combined in Dictyostelium. This is a leading system for understanding signalling in differ-
entiating cell populations, as the signalling machinery is highly conserved in mammalian
cells [27]. The decision to differentiate in Dictyostelium is accessible to noninvasive imaging
from submicron to millimetre length scales [28], so it is possible to directly monitor the
entire heterogeneous decision-making process within individual cells in the context of
the collective. To define the signalling history of a cell, the dynamics of the major extra-
cellular signals can be quantified in relation to cell positions in the niche. In addition,
these signals are amenable to precise genetic and optogenetic manipulation. Crucially, the
transcriptional outputs underlying decision making can be directly measured in real time
using technology developed in Dictyostelium to image transcription dynamics in single
cells [29–32] (Figure 2).–
ore “bursty” 
–
Figure 2. Imaging transcription in living cells. Images are stills from movies of Dictyostelium cells with different actin
genes tagged using the MS2 RNA detection system. Nascent RNA appears at the site of transcription as a fluorescent
spot. Different genes show different spot appearance and disappearance kinetics, with act5 and act6 genes being more
“bursty” and act8 more constitutive. Image reproduced from [31]. Bursting transcription is now known to be conserved in
all forms of life, from bacteria to mammalian cells, and has been implicated as a driver of cellular heterogeneity in diverse
contexts- such as underlying HIV latency, the persistence of bacteria and cancer cells exposed to drug treatment, and cell
fate separation during development.
3. Self-Generated Chemotactic Gradients
Directed cell movement in response to chemical gradients, or chemotaxis, is used by
many cells, including Dictyostelium, cancer cells of different origins (especially pancreatic
cancer and melanoma) and immune cells such as neutrophils. In this scenario, Dictyostelium
acts as a gateway organism; its simple genome, ease of culture and our huge library of
mutants (both in our own freezers [33] and through Dictybase [34]) make it an ideal subject
for proof-of-principle experiments.
Most research laboratories that study chemotaxis start from the basis that someone
else creates the gradient, and the chemotactic cell’s sole job is to interpret it [35–37]. This
is unlikely to occur very often in real physiology. Cells can obtain more information and
thus respond more strongly by breaking down attractants while they move [38]. In a more
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exaggerated situation, cells can create their own gradients, even when none are initially
present in the environment. If an attractant is plentiful, cells are localized, and they break
down the attractant. Then, gradients of some sort are inevitable, with the highest density
of cells corresponding to the low end of the gradient. These are known as “self-generated”
gradients [39], and Dictyostelium is one of the best organisms for studying them.
Several features of Dictyostelium biology make it ideal. The attractants are well un-
derstood, and chemical analogues with different properties are available, for example,
attractants that cannot be broken down but which still trigger cell movement. Cyclic
AMP (cAMP) is the most-studied attractant and can be mimicked by the non-hydrolysable
molecule Sp-cAMPS, where cell responses are strikingly different [40]. Dictyostelium uses
cell-surface enzymes to break down its favoured chemoattractants. cAMP is degraded
by cAMP phosphodiesterase (PdsA) [41], and folate secreted by bacteria is broken down
by folate deaminase, which has been identified biochemically [42] but is yet to be cloned.
Sp-cAMPS is not altered by PdsA, and similarly, methotrexate is unaffected by folate deami-
nase. The combination of receptor mutants, migration mutants, chemoattractant analogues
and a vibrant research community has allowed us to define self-generated gradients better
in Dictyostelium than anywhere else.
The most arresting demonstration of the power of self-generated gradients is shown
by cells that can solve mazes [43]. We built mazes of different complexities using the
same process as was used in the Dictyostelium Cell Race [44]—PDMS silicone rubber cast
on etched silicon blanks. Using these, it was shown that cells can make well-informed
decisions about the best path they can take. Without seeing the path or any a priori
gradients or information, the self-generation probes the environment and allows the cells
to discover where they should go before they arrive at decision points. Many other cells
use the same process, but Dictyostelium has been the organism of choice to understand it.
4. Macropinocytosis
Another area where research in Dictyostelium has made a significant impact is the
study of macropinocytosis. This is the process by which cells engulf large volumes of
extracellular fluid via the extension of large cup-shaped protrusions that close and collapse
in upon themselves. This causes the formation of a large intracellular vesicle containing
extracellular proteins and macromolecules which immediately begins to be processed and
digested within the cell.
Whilst macropinocytosis has been subverted by vertebrate immune cells such as
macrophages and dendritic cells to survey the environment and capture antigens for
presentation, the original evolutionary role for drinking extracellular fluid as food is most
likely to feed [45]. This is exemplified in Dictyostelium and other protists, which can use
macropinocytosis as an alternative to phagocytic feeding, allowing them to grow in liquid
medium (Figure 3). Importantly, this has been conserved all the way to human cells, and
although most unstimulated cells do not take up much fluid, macropinocytosis is highly
upregulated in many cancers, endowing them with the ability to eat extracellular proteins to
sustain their unrestrained growth [46]. This, and the finding that macropinocytosis acts as
an entry mechanism for bacterial and viral pathogens as well as prion aggregates and even
biotherapeutics such as RNA vaccines has led to a surge of interest in macropinocytosis in
recent years [47].
Dictyostelium has proven to be an ideal model system for investigating the organi-
sation and dynamics of macropinocytic cups as well as determining how the resultant
vesicles are processed. Key to this are the large and frequent cups formed by these cells.
When combined with high resolution microscopy, this allows macropinocytosis to be
observed in greater detail than in any other system. With the added advantages of sim-
ple genetic manipulation and the ability to perform genetic screens, Dictyostelium pro-
vides a unique opportunity to understand the basic and highly conserved mechanisms of
macropinocytosis.
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Figure 3. Macropinocytic cup formation in Dictyostelium. A 3D projection from a timelapse of
Dictyostelium cells co-expressing a reporter for the signalling lipid PIP3 (PH-pkgE-RFP) that designates
the cup interior and is encircled by a ring of the SCAR/WAVE complex (shown by NAP1-GFP).
Images taken by lattice light sheet microscopy. Bar = 10 µM.
This has allowed major advances, such as the proposal of a “template” model for
macropinocytic cup formation, where the cup shape is formed by organising a ring of actin
polymerisation around a central domain of the signalling lipid PIP3 [48]. Dictyostelium
studies have also led the way to understanding how the Ras and Rac small GTPases com-
bine to regulate cup size and dynamics [49,50] as well as illuminating how the cytoskeleton
is differentially regulated across the cup [51,52]. Large cups make large vesicles, which are,
again, highly tractable to imaging and can be followed over time. This allows intracellular
processing to be observed directly, leading to discoveries, such as how surface proteins are
retrieved from macropinosomes to save them from deg adation [53].
Whilst interesting and important themselves, studies of macropinocytosis have an
additional impact beyond fluid uptake. Macropinocytosis shares its evolutionary origins
and nearly all of its engulfment and processing machinery with bacteria feeding by phago-
cytosis. Macropinocytosis studies, therefore, often also have implications for phagocytosis,
which can easily be studied in parallel in Dictyostelium [49–51,53]. As a professional phago-
cyte, Dictyostelium has been used extensively as a model host to study interactions with a
wide range of both bacterial and fungal pathogens [19,54]. This adds significant value to
studies of the core macropinocytosis and phagocytosis machinery.
Recent years have seen a rapid increase our understanding of macropinocytosis.
Dictyostelium research has been at the forefront throughout, proving to be a useful and
highly conserved model. Many questions still remain, such as the mechanism by which
actin polymerisation is enticed into a ring, how the cups close, how the cell recognises a
newly formed macropinosome and how maturation is regulated. It, therefore, seems likely
that research using Dictyostelium will remain important and contribute further information
for some time to come.
5. Targeting Histone Post-Translational Modifications
Post-translational modifications of histone proteins play a vital role in regulating
the interaction of nucleosomes with proteins involved in a range of processes, including
gene expression and DNA repair. A large number of modifications have been described
in mammalian cells with combinations adding to the complexity. Histone modifications
are frequently aberrant in cancer cells, and a number of pharmacological inhibitors of
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modifying enzymes specifically target cancer cells. Dictyostelium offers a unique system
to study the mechanistic function of histone modifications in a system with multicellular
complexity. Modifications are highly conserved, including many that are absent in models
such as yeast. Importantly the genome contains mainly single copies of genes encoding
histone variants, unlike mammalian cells which can contain more than ten gene copies,
precluding genetic manipulation [55]. This facilitates rapid generation of Dictyostelium
strains with mutations introduced into the endogenous genes to generate versions of
histones that lack individual modification sites [56,57]. There is an emerging role of
the nuclear lamina in epigenetic regulation through histone modifying enzymes. Since
many nuclear lamina components of mammalian cells are conserved in Dictyostelium, this
makes the system even more attractive to study post-translational histone modifications.
Dictyostelium also shows reduced redundancy in modifying enzymes, often having a
single orthologue [58], which again facilitates the generation of strains lacking specific
modifications and genetic screens to characterise their role as well as identify drug-resistant
mutants. Thus, Dictyostelium can be used to understand the mechanism of action and
modes of resistance against inhibitors which impact histone modification and are currently
in use in the clinic for cancer therapy.
Histones associated with active genes are acetylated and deacetylase inhibitors (KDACi)
that specifically induce the apoptosis or differentiation of cancer cells. In mammalian cells,
Histone 3 Lysine 4 (H3K4) trimethylated histones, enriched at promoters, are the most
rapidly acetylated during treatment of cells with KDACi, revealing dynamic turnover of
acetylation on these histones [59]. This link is conserved in Dictyostelium [60], and KDACis
inhibits development, allowing the importance of this process in the mechanism of action of
KDACi to be determined [61]. Strains that are deficient in the only H3K4-methyltransferase
gene show resistance to KDACi inhibition of development. Mutation of the methylation
site in the endogenous H3 variant genes generates strains lacking the dynamic pool of
acetylated histones and that also show resistance. This reveals the importance of this pool
of dynamically acetylated histones in the mode of action of these drugs. Gene disruption
studies have revealed that a subunit of an acetyltransferase that binds H3K4me is required
for this link, suggesting that drugs that target this binding will provide an alternative
to KDACi. Many cancer cells show overexpression of this protein, providing a potential
biomarker for sensitivity to this class of drugs.
A distinct histone modification that is targeted in cancer treatment is ADP-ribosylation.
DNA damage, such as double strand breaks, can lead to genome instability and cancer.
ADP-ribosyltransferases (PARPs) trigger ADP-ribosylation of histones at damage sites,
but the mechanistic consequences of this are not known. PARP inhibitors are currently
used to treat breast and ovarian cancers that are deficient in one pathway of double strand
break repair [62]. DNA damage-responsive ADP-ribosyltransferases are conserved in
Dictyostelium, although they are missing in other model organisms [23], and characterisation
of strains deficient in single or multiple related enzymes have revealed redundant roles in
repair of different types of DNA damage [63,64]. This has important implications for the use
of specific inhibitors for individual PARPs in cancer cells with defects in different response
pathways. Multiple histones are modified at different sites, so strains with endogenous
histone proteins lacking combinations of ADP-ribosylation sites are being generated to
reveal their importance in genome stability [65].
Studies on Dictyostelium are, therefore, providing unique insights into the importance
and mechanisms of action of these histone modifications and their roles in determining the
sensitivity of cancer cells to these chemotherapeutic drugs.
6. Evolutionary Membrane Biology
Despite the ancient origins of the Amoebozoa, the proteome of the amoeba Dic-
tyostelium remains remarkably similar to that of animals, providing an opportunity to
compare functions of evolutionarily early but undescribed proteins in membrane biology.
This is particularly relevant for the conservation of mitochondrial proteins and functions,
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established areas of Dictyostelium research [14], including one of the most recently discov-
ered protease types, the ‘rhomboid’ proteases. These enzymes operate in the hydrophobic
environment of the membrane, often providing a regulatory switch as they cleave their
substrates. They can be described as being necessary for life, since they are ubiquitous
across evolution. Recently, these proteins have been suggested to be involved in human
disease as well as providing an interesting paradigm for signalling and regulation from
the membrane. In addition, work on organellar rhomboids of plants [66,67] showed roles
in membrane lipid composition for plastid rhomboid orthologues with pleiotropic effects
that extend to floral morphology. Regulation of the lipid content of membranes may be
an important conserved function of rhomboids, since a mitochondrial representative was
also shown to cleave a lipid transfer protein, governing the dimerisation of ATP synthase
and cristae morphology [68]. In addition to studying the four active rhomboids of Dic-
tyostelium [69], this similarity in mitochondrial regulation across organisms has enabled
its use as a model to investigate how mitochondria might be treated to reduce age-related
macular degeneration [70].
The parallels between plant and amoeba membrane biology have also inspired work
on a group of membrane transporter proteins. Multidrug and toxin efflux (MATE) trans-
porters are encoded by large multigene families in plants, operating in ion and pigment
transport at the vacuole [66]. The smaller, less selective groups in bacteria are a key cause
of antibiotic resistance. As MATE proteins are also found in human cell membranes, they
can contribute to drug resistance in human anticancer therapy. Dictyostelium, again, closely
parallels human cells, with a pair of MATE proteins whose roles had not previously been
documented. Ongoing research in this area is exploring the roles of MATE proteins, includ-
ing their substrate specificity, physiological relevance (for example in phagocytosis of prey
bacteria), and the parallels in gene expression between the amoeba transporters and those
in the human kidneys and liver [71].
Thus, even though Dictyostelium is a relatively simple organism, it provides a route for
understanding the modes of action of new drug treatments. Using flavonoids as a model
drug class, applied research includes investigation of the ability of Dictyostelium to efflux
compounds during assays of activity and the repurposing of a plant reporter for use as a
simple but quantifiable indicator of the entry and efflux of polyphenolic compounds [71].
7. Cellular Mechanisms Underlying Multicellular Morphogenesis
A major goal in developmental studies is to understand the principles that underlie
the integration of critical cellular behaviours by cell signalling to drive multicellular devel-
opment and morphogenesis. This has been investigated in a wide variety of organisms
ranging from very simple to very complex. Dictyostelium is a simple organism found at
the boundary between unicellular and multicellular organisms in the tree of life. The
developmental cycle has been studied extensively, since development takes only 24 h and
is a simple system as there are only a few cell types and the growth and developmental
phases are separated in different parts of the lifecycle [72]. The multicellular developmental
cycle is triggered by starvation and occurs essentially in the absence of cell division, but
the time of exit biases the differentiation of the cells into stalks or spores [73]. The various
multicellular stages, aggregates, mounds, migrating slugs and fruiting bodies are formed
through the rearrangement of differentiating cells in space and time.
3’-5’cyclic AMP (cAMP), the chemoattractant that controls the aggregation phase of
development, was one of the first chemoattractants to be identified [74]. Triggered by
starvation, cAMP starts to be produced and secreted by the aggregating cells in a periodic
manner. Release of cAMP starts an autocatalytic amplification cycle, resulting in rapid
secretion of cAMP. This secreted cAMP is detected and amplified and secreted by sur-
rounding cells to propagate as spiral and concentric waves of chemoattractant through
the population of cells [27,75]. These chemoattractant waves propagate from aggregation
centres, where they are periodically initiated outward and direct the inwards chemotac-
tic movement of the cells towards the aggregation centre. Dictyostelium can be used to
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study the dynamics of the cell–cell signalling mechanisms that control the movement
behaviours of the differentiating cells and the feedback of these cell movements through
cell signalling using a combination of experimental and modelling approaches. We have
shown that waves of chemoattractant organise cell movement not only during aggregation
but also in the later multicellular stages of development. We initially developed methods
to visualise the waves of chemoattractant via light scattering changes associated with
periodic cell movements during aggregation in mounds and in migrating slugs, followed
by visualisation of changes in phosphatidyl-inositide phosphate signalling associated with
cAMP mediated signal transduction, as reviewed in [76]. More recently, we have been
able to monitor the dynamics of cAMP signalling in vivo during all stages of the lifecycle
using cAMP specific FRET constructs (Figure 4) while simultaneously characterising the






Figure 4. Comparison of cAMP and optical density waves during late aggregation. (A) Image
showing the dynamics of cAMP waves in a streaming aggregate. Intracellular cAMP variations
were measured using a cAMP specific FRET sensor. The sensor is based on the mammalian EPAC
cAMP binding protein, and cAMP variations are measured as donor-acceptor emission ratios [77].
(B) Optical density image of the same aggregate as shown in (A). (C) FRET ratio and optical density
changes as functions of time measured in the circle region shown in (A).
Due to the visualisation of both the dynamics of the chemotactic signals and the result-
ing chemotactic response and interactions between them during all stages of development,
it has been possible to classify Dictyostelium morphogenesis as a highly self-organised
process based on two essential cell behaviours: excitable cell–cell signalling and chemo-
taxis, resulting in robust multicellular morphogenesis [78]. Many questions remain to be
resolved regarding the detailed molecular mechanisms associated with cell polarisation
and cytoskeletal dynamics during the chemotactic response and the role of cell contact in
cell polarisation in the later stages of development [79–82].
8. Molecular Medicine and Drug Discovery
Epilepsy is one of the most common serious neurological conditions worldwide. De-
spite a century of research into the treatment of this chronic condition, around one-third
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of patients continue to experience seizures, even though current medicines available [83].
Thus, there remains a clear and urgent need to develop better treatments for these individu-
als. The origins of seizures is largely considered to be a slight imbalance in the excitation or
inhibition of neuronal signalling, giving rise to localised or generalised hyper-activation of
regions of the brain and a wide range of behavioural responses defined as seizures [84]. Due
to these mechanisms, the vast majority of research into epilepsy and novel treatments focus
on synaptic signalling and employ animal models, and a wide range of compounds have
shown efficacy in blocking seizure-like activity. How these drugs work at the molecular
and cellular levels has often been proposed but rarely agreed on.
Research using Dictyostelium as a simple biomedical model has provided an inno-
vative approach to investigate molecular mechanisms for epilepsy treatments, and from
this, the development of potential new drugs that have been shown to block seizures has
occurred. This model provides the ability to assess the bioactivity of one of the most widely
used treatments for epilepsy and bipolar disorder, valproate (valproic acid; VPA) [85], a
short-chain branched fatty acid (2-propylpentanoic acid). This drug provides excellent
broad-spectrum seizure control but is likely to be withdrawn from widespread use due
to its significant side effect of teratogenicity [86,87]. To identify the molecular mechanism
of valproate using Dictyostelium, initial studies focused on developmental effects to show
that physiologically relevant concentrations of valproate block fruiting body formation,
suggesting a specific molecular effect related to cell signalling in development [88]. To
investigate this mechanism, and since early development is regulated by cAMP-induced
chemotaxis, leading to the formation of phosphoinositides, further studies found that val-
proate treatment reduces phosphoinositide signalling (formation of phosphatidylinositol
phosphate [PIP] and phosphatidylinositol 4,5-bisphosphate [PIP2]) (Figure 5), a mechanism
that had not been identified in other models [89]. The effect on phosphoinositide turnover
was then confirmed using in vitro and in vivo analyses in rodent models, and the results
suggested that a similar effect is likely in humans, potentially related to epilepsy treat-
ment [90]. Identification of this mechanism then enabled a low-throughput drug screen to
identify related compounds with improved potency. Here, over 100 related compounds
were assessed for the ability to reduce phosphoinositol signalling [89] to identify a range
of structurally specific medium-chain fatty acids with potent activity in the reduction of
phosphoinositide signalling. The relevance of these compounds for epilepsy treatment
was then confirmed, and many of them were found to provide more potent seizure control
in ex vivo mammalian seizure models [89,91,92]. In collaboration with the US Epilepsy
Therapy Screening program, several of these compounds were also shown to block seizure
activity in a range of animal models representing different types of epilepsy, including
for models of generalized tonic-clonic seizures, focal seizures and absence seizures [92].
Interestingly, one of the compounds showing potent seizure control was decanoic acid,
which is a key component of a diet used to treat patients with drug-resistant epilepsy [93].
Further analysis of decanoic acid identified multiple antiepileptic mechanisms, which were
validated in mammalian models, including direct inhibition of AMPA receptors [94] and
inhibition of mTORC1 [95]. Excitingly, several of the compounds identified, including
trans-4-butylcyclohexane carboxylic acid (4BCCA) and 4-ethyloctanoiac acid (4EOA) [92],
showed improved potency over valproate in multiple ex vivo and in vivo models and are
likely to lack teratogenic side effects, providing a promising new medicinal approach for
the treatment of patients with generalised and drug-resistant epilepsy.
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Figure 5. Identifying a molecular mechanism associated with valproate that acts on Dictyostelium
phosphoinositide signalling. (A) Dictyostelium cells, induced to the early aggregation stage, were
permeabilized in the presence of radio-labelled ATP and phosphatase inhibitors for 6, 9 or 60 min in
the absence (-) or presence of 0.5 mM valproate (VPA). (B) Levels of PIP and PIP2 were quantified
in comparison to total lipids (Cont). This assay identified, for the first time, that valproate reduces
phosphoinositide signalling and was subsequently used to identify a range of second-generation val-
proate replacements that showed strong seizure control in pre-clinical models. * p < 0.05; *** p < 0.001
for PIP levels, from [89].
Thus, through using Dictyostelium as a pharmacogenetic model to identify mecha-
nism(s) of action of commonly used medicines, it is possible to translate discoveries to
preclinical models and identify more potent drugs with reduced side effects.
9. Conclusions
The use of Dictyostelium as a tractable model for biological research has progressed
from initial studies regarding the unusual process of cell aggregation and development
shown by the model, to now include a wide array of research areas. British research centres
have focused on understanding how future changes in cell fate are determined, how cells
function in cell-to-cell signalling, how cells consume extracellular liquid, how cells regulate
gene expression and DNA repair, fundamental aspects of cell membranes and proteins
within membranes, processes by which cells change structure and function in development,
and investigations of the mechanisms of action of medicines and bioactive natural products.
Underlying all these areas of study is the relative simplicity of the system (at both a genetic
level and in development) and the range of specific research approaches that are difficult
to use in other research models. In addition, the close-knit and collaborative research
community and support by the international resource for the model system (Dictybase)
provides a strong and vibrant platform for innovative and translational research. Thus,
Dictyostelium provides an excellent research model with the ability to significantly impact a
wide range of fields within biology.
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